| exposure_material_preferred ;
exposure_material_id | | | |
| 2008-2009 trivalent influenza vaccine ; VO:0004809 | 2008-2009 trivalent influenza vaccine | | |
| 2011-2012 trivalent inactivated vaccine (A/California/7/09 (H1N1), A/Perth /16/2009 (H3N2), and B/Brisbane/60/2008) ; VO:0004810 | 2011-2012 trivalent inactivated vaccine (A/California/7/09 (H1N1), A/Perth /16/2009 (H3N2), and B/Brisbane/60/2008) | | |
| ACWY Vax ; VO:0003138 | ACWY Vax | | |
| Ad35.CS.01 malaria vaccine ; VO:0004993 | A P. falciparum malaria vaccine that is formed by tull length CS-expressing replication-deficient recombinant human adenovirus 35. | | |
| AdCOVID ; VO_0005153 | AdCOVID | | |
| Alternaria alternata ; NCBITaxon:5599 | species, ascomycetes | | |
| BCG Vaccine ; VO:0000771 | BCG Vaccine is a Mycobacterium tuberculosis vaccine that is a live attenuated strain of Mycobacterium bovis (Bacillus Calmette Guerin; BCG). | | |
| Borreliella burgdorferi ; NCBITaxon:139 | Borreliella burgdorferi | | |
| Chikungunya virus ; NCBITaxon:37124 | Found from reported data using NCBI Taxomony Dump: 37124 | | |
| Chlamydia trachomatis ; NCBITaxon:813 | Chlamydia trachomatis | | |
| CureVac AG ; VO:0005208 | CureVac AG | | |
| Cytomegalovirus ; NCBITaxon:10358 | Cytomegalovirus | | |
| Dengue virus 1 ; NCBITaxon:11053 | Dengue virus 1 | | |
| Dengue virus 2 ; NCBITaxon:11060 | Dengue virus 2 | | |
| Dengue virus 3 ; NCBITaxon:11069 | Found from reported data using NCBI Taxomony Dump: 11069 | | |
| Dengue virus ; NCBITaxon:12637 | Dengue virus | | |
| diphtheria, tetanus and whole cell pertussis vaccine ; VO:0003106 | diphtheria, tetanus and whole cell pertussis vaccine | | |
| Diphtheria-Tetanus-Pertussis vaccine ; VO:0000738 | Diphtheria-Tetanus-Pertussis vaccine | | |
| Dryvax ; VO:0000035 | a vaccinia virus vaccine that is a freeze-dried calf lymph smallpox vaccine, specifically, Dryvax is a live-virus preparation of vaccinia prepared from calf lymph. | | |
| Engerix-B ; VO:0010711 | Engerix-B | | |
| Fluarix ; VO:0000045 | Fluarix | | |
| FluMist ; VO:0000044 | FluMist | | |
| Fluvirin ; VO:0000046 | Fluvirin | | |
| Fluzone ; VO:0000047 | Fluzone | | |
| Hepacivirus C ; NCBITaxon:11103 | Found from reported data using NCBI Taxomony Dump: 11103 | | |
| Hepatitis B surface antigen vaccine ; VO_0003150 | A Hepatitis B virus vaccine that uses recombinant Hepatitis B surface antigen as the antigen | | |
| Hepatitis B Surface Antigen Vaccine Injection [Heplisav-B] ; VO_0003270 | Hepatitis B Surface Antigen Vaccine Injection [Heplisav-B] | | |
| Hepatitis B Surface Antigen Vaccine Prefilled Syringe [Engerix-B] ; VO_0003258 | Hepatitis B Surface Antigen Vaccine Prefilled Syringe [Engerix-B] | | |
| Hepatitis B virus ; NCBITaxon:10407 | Hepatitis B virus | | |
| Hepatitis B virus vaccine ; VO_0000644 | A viral vaccine that protects against infection with Hepatitis B virus. | | |
| HEPLISAV-B ; VO:0003152 | A Hepatitis B surface antigen viral vaccine that utilizes a cytidine-phosphate-guanosine oligodeoxynucleotide (CpGODN) 1018, as an adjuvant. | | |
| Human alphaherpesvirus 3 ; NCBITaxon:10335 | Human alphaherpesvirus 3 | | |
| Human gammaherpesvirus 4 (Epstein-Barr virus) ; NCBITaxon:10376 | Human gammaherpesvirus 4 (Epstein-Barr virus) | | |
| human immunodeficiency virus infectious disease ; DOID:526 | A viral infectious disease that results in destruction of immune system, leading to life-threatening opportunistic infections and cancers, has_material_basis_in Human immunodeficiency virus 1 or has_material_basis_in Human immunodeficiency virus 2, which are transmitted by sexual contact, transmitted by transfer of blood, semen, vaginal fluid, pre-ejaculate, or breast milk, transmitted by congenital method, and transmitted by contaminated needles. The virus infects helper T cells (CD4+ T cells) which are directly or indirectly destroyed, macrophages, and dendritic cells. The infection has symptom diarrhea, has symptom fatigue, has symptom fever, has symptom vaginal yeast infection, has symptom headache, has symptom mouth sores, has symptom muscle aches, has symptom sore throat, and has symptom swollen lymph glands. | | |
| human immunodeficiency virus vaccine ; VO_0000295 | A viral vaccine that protects against infection with human immunodeficiency virus that causes AIDS. | | |
| Human rhinovirus A16 ; NCBITaxon:31708 | Found from reported data using NCBI Taxomony Dump: 31708 | | |
| inactivated influenza vaccine ; VO_0001176 | inactivated influenza vaccine is an inactivated viral vaccine that targets at influenza viral infections. | | |
| Influenza A H1N1 2009 Monovalent Vaccine Novartis ; VO:0000081 | Influenza A (H1N1) 2009 Monovalent Vaccine (Novartis) | | |
| Influenza A virus (A/California/7/2009(H1N1)) ; NCBITaxon:1316510 | Found from reported data using NCBI Taxomony Dump: 1316510 | | |
| Influenza A virus (A/reassortant/FluMist(California/07/2009 x Ann Arbor/6/1960)(H1N1)) ; NCBITaxon:1701435 | Found from reported data using NCBI Taxomony Dump: 1701435 | | |
| Influenza A virus ; NCBITaxon:11320 | Influenza A virus | | |
| Influenza virus vaccine ; VO:0000642 | A viral vaccine that protects against infection with influenza virus. | | |
| Influvac ; VO_0000867 | Influvac is an Influenza virus vaccine that is manufactured by Solvay Pharma. | | |
| Ionizing Radiation ; NCIT:C17052 | High-energy radiation capable of producing ionization in substances through which it passes. | | |
| Johnson & Johnson COVID-19 vaccine ; VO:0005159 | A SARS-CoV-2 recombinant viral vector vaccine composed of Ad26 vector expressing S protein, Ad26COVS1; JNJ-78436735 | | |
| LC16m8 ; VO:0004091 | LC16m8 | | |
| live attenuated influenza vaccine ; VO_0001178 | live attenuated influenza vaccine is a live attenuated vaccine that protects against influenza viral infection. | | |
| Menactra ; VO:0000071 | Menactra | | |
| Meningococcal Polysaccharide Vaccine, Groups A & C, Menomune A/C ; VO:0010725 | Meningococcal Polysaccharide Vaccine, Groups A & C, Menomune A/C | | |
| Menveo ; VO:0001246 | Menveo | | |
| Moderna COVID-19 vaccine ; VO:0005157 | A SARS-CoV2 RNA vaccine made of lipid nanoparticle with mRNA which encodes the S-2P antigen, made of the SARS-CoV-2 glycoprotein with a transmembrane anchor and intact S1-S2 cleavage site | | |
| MRKAd5 HIV-1 gag/pol/nef ; VO:0003133 | The MRK adenovirus type 5 human immunodeficiency virus type 1 clade B gag/pol/nef vaccine is a replication-incompetent adenovirus type 5-vectored vaccine that elicits cell-mediated immunity against conserved human immunodeficiency virus proteins. | | |
| MVA85A ; VO:0003120 | MVA85A | | |
| Mycobacterium tuberculosis ; NCBITaxon:1773 | Mycobacterium tuberculosis | | |
| NVX-CoV2373 ; VO:0005155 | A SARS-CoV 2 (rSARS-CoV-2) subunit vaccine made of nanoparticles composed of a trimeric full-length SARS-CoV-2 spike glycoprotein and Matrix-M1 adjuvant | | |
| Other ; Other | Other | | |
| Oxford AstraZeneca COVID-19 vaccine ; VO:0005158 | A SARS-CoV2 recombinat vector vaccine made of a chimpanzee adenovirus-vectored vaccine expressing the SARS-CoV-2 spike protein | | |
| P. falciparum RTS,S/AS01 ; VO:0003093 | A malaria vaccine that consists of hepatitis B surface antigen virus-like particles, incorporating a portion of the Plasmodium falciparum-derived circumsporozoite protein and a liposome-based adjuvant. | | |
| Pfizer BioNTech COVID-19 vaccine ; VO:0004987 | A SARS-CoV-2 RNA vaccine formed from a lipid nanoparticle-formulated trimerized SARS-CoV-2 receptor-binding domain | | |
| PfSPZ Vaccine ; VO:0004910 | a malaria vaccine that protects against malaria caused by Plasmodium falciparum | | |
| PfSPZ-CVac ; VO:0004911 | a malaria vaccine that protects against malaria caused by Plasmodium falciparum | | |
| PfSPZ-GA1 ; VO:0004912 | a malaria vaccine that protects against malaria caused by Plasmodium falciparum | | |
| Plasmodium coatneyi ; NCBITaxon:208452 | Found from reported data using NCBI Taxomony Dump: 208452 | | |
| Plasmodium cynomolgi strain B ; NCBITaxon:1120755 | Found from reported data using NCBI Taxomony Dump: 1120755 | | |
| Plasmodium cynomolgi strain Ceylon ; NCBITaxon:5829 | Found from reported data using NCBI Taxomony Dump: 5829 | | |
| Plasmodium falciparum ; NCBITaxon:5833 | malaria parasite P. falciparum | | |
| Plasmodium falciparum vaccine ; VO:0000087 | a malaria vaccine that protects against malaria caused by Plasmodium falciparum. | | |
| Plasmodium vivax ; NCBITaxon:5855 | Found from reported data using NCBI Taxomony Dump: 5855 | | |
| Pneumovax 23 ; VO:0000088 | Pneumovax 23 | | |
| quadrivalent inactivated influenza vaccine ; VO_0010196 | quadrivalent inactivated influenza vaccine | | |
| Respiratory syncytial virus ; NCBITaxon:12814 | Respiratory syncytial (sin-SISH-uhl) virus, or RSV, is a common respiratory virus that usually causes mild, cold-like symptoms. Most people recover in a week or two, but RSV can be serious, especially for infants and older adults. | | |
| rVSV-EBOV ; VO:0004660 | An Ebola virus vaccine that uses a recombinant vesicular stomatitis virus (rVSV) vector expressing an Ebola filovirus glycoprotein | | |
| SARS Coronavirus 2 B.1.1.529 ; UMLS_CUI:C5564753 | WHO Name: Omicron. A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: deletions of the amino acids at positions 69/70, 143/145 and 212 and amino acid substitutions A67V, T95I, G142D, N211I, G339D, S371L, S373P, S375F, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H, D796Y, N856K, Q954H, N969K and L981F. (NCI) | | |
| SARS Coronavirus 2 BA.1 ; UMLS_CUI:C5706968 | WHO Name: Omicron. A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: deletions of the amino acids at positions 69/70, 143/145 and 212 and amino acid substitutions A67V, T95I, G142D, N211I, G339D, S371L, S373P, S375F, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H, N764K, D796Y, N856K, Q954H, N969K and L981F. (NCI). | | |
| SARS Coronavirus 2 BA.2 ; UMLS_CUI:C5670041 | WHO Name: Omicron. A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: deletions of the amino acids at positions 25/27 and amino acid substitutions T19I, L24S, G142D, V213G, G339D, S371F, S373P, S375F, T376A, D405N, R408S, K417N, N440K, S477N, T478K, E484A, Q493R, Q498R, N501Y, Y505H, D614G, H655Y, N679K, P681H, N764K, D796Y, Q954H and N969K. (NCI) | | |
| SARS Coronavirus 2 BA.3 ; UMLS_CUI:C5706967 | WHO Name: Omicron. A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: deletions of the amino acids at positions 69/70, 143/145 and 212 and amino acid substitutions A67V, G142D, N211I, D614G, H655Y, N679K, P681H, N764K, D796Y, Q954H and N969K. (NCI) | | |
| SARS Coronavirus 2 BA.4 ; UMLS_CUI:C5706966 | WHO Name: Omicron. A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: deletions of the amino acids at positions 25/27 and 69/70 and amino acid substitutions T19I, L24S, G142D, V213G, G339D, S371F, S373P, S375F, T376A, D405N, R408S, K417N, N440K, L452R, S477N, T478K, E484A, F486V, Q498R, N501Y, Y505H, D614G, H655Y, N679K, P681H, N764K, D796Y, Q954H and N969K. This variant has two novel amino acid variations, a D61L substitution in the ORF6 protein and a L11F in the ORF7b protein. (NCI) | | |
| SARS Coronavirus 2 BA.5 ; UMLS_CUI:C5706965 | WHO Name: Omicron. A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: deletions of the amino acids at positions 25/27 and 69/70 and amino acid substitutions T19I, L24S, G142D, V213G, G339D, S371F, S373P, S375F, T376A, D405N, R408S, K417N, N440K, L452R, S477N, T478K, E484A, F486V, Q498R, N501Y, Y505H, D614G, H655Y, N679K, P681H, N764K, D796Y, Q954H and N969K. (NCI) | | |
| SARS Coronavirus 2 C.37 ; UMLS_CUI:C5556619 | WHO Name: Lambda. A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: deletions of the amino acids at positions 247-253 and amino acid substitutions G75V, T76I, L452Q, F490S, D614G and T859N. (NCI) | | |
| SARS-CoV-2 ; NCBITaxon:2697049 | Severe acute respiratory syndrome coronavirus 2, equivalent: 2019-nCoV | | |
| SARS-CoV-2 B.1.1.7 variant ; UMLS_CUI:C5433393 | A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: deletions of the amino acids at positions 69, 70 and 144 and amino acid substitutions N501Y, A570D, D614G, P681H, T716I, S982A and D1118H. The substitutions E484K, S494P and K1191N have also been detected in some but not all sequences for this lineage. (NCI). Also known as B.1.1.7, 20I/501Y.V1, VOC - 202012/01, and UK variant (LNC) | | |
| SARS-CoV-2 B.1.351 variant ; UMLS_CUI:C5433395 | A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: deletions of the amino acids at positions 241-242 and amino acid substitutions D80A, D215G, K417N, E484K, N501Y, D614G and A701V. (NCI). Also known as B.1.351, 501Y.V2, and South Africa variant (LNC) | | |
| SARS-CoV-2 B.1.617.2 lineage ; UMLS_CUI:C5548982 | Also known as WHO Delta variant (LNC) | | |
| SARS-CoV-2 D614G variant ; UMLS_CUI:C5433391 | Known as SARS-CoV-2 USA-WA1/2020. https://www.ncbi.nlm.nih.gov/biosample/SAMN18527778 | | |
| SARS-CoV-2 Mu variants ; UMLS_CUI:C5564751 | A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: an amino acid insertion 146N and amino acid substitutions T95I, Y144T, Y145S, R346K, E484K, N501Y, D614G, P681H and D950N. (NCI). Also known as SARS-CoV-2 B.1.621. | | |
| SARS-CoV-2 P.1 variant ; UMLS_CUI:C5433398 | A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: amino acid substitutions L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, D614G, H655Y, T1027I and V1176F. (NCI). Also known as SARS-CoV-2 Gamma; P.1 | | |
| SARS-CoV-2 P.2 variant ; UMLS_CUI:C5433392 | WHO Name: Zeta. A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: amino acid substitutions E484K, D614G and V1176F. The substitution F565L has also been detected in some but not all sequences for this lineage. (NCI). | | |
| Schistosoma mansoni ; NCBITaxon:6183 | Found from reported data using NCBI Taxomony Dump: 6183 | | |
| Shigella flexneri 2a ; NCBITaxon:42897 | Shigella flexneri, serovar 2a. Extended spectrum beta-lactamase producing Shigella flexneri serovar 2a (133131000112102) SNOMEDCT_US | | |
| Shigella sonnei ; NCBITaxon:624 | A lactose-fermenting bacterium causing dysentery | | |
| Sinopharm (BBIBP-CorV) ; VO:0005166 | A SARS-CoV-2 inactivated whole virus vaccine that produced in Vero cells that is developed by the Beijing Institute of Biological Products. | | |
| Sputnik V ; VO:0005163 | A SARS-CoV-2 recombinant viral vector vaccine composed of Ad26 and Ad5 vectors expressing S protein that lyophilised. | | |
| Stamaril ; VO:0003139 | It is live attenuated YFV vaccine strain 17D manufactured in China, France, Senegal, and the USA. In powder and solvent for suspension for injection in pre-filled syringe. | | |
| Staphylococcus aureus ; NCBITaxon:1280 | Staphylococcus aureus is a Gram-positive, round-shaped bacterium that is a member of the Firmicutes, and it is a usual member of the microbiota of the body, frequently found in the upper respiratory tract and on the skin. | | |
| unidentified ; NCBITaxon:32644 | Found from reported data using NCBI Taxomony Dump: 32644 | | |
| Vaccinia virus LC16M8 ; NCBITaxon:10248 | Found from reported data using NCBI Taxomony Dump: 10248 | | |
| Varicella-zoster virus vaccine ; VO:0000669 | a Herpesvirus vaccine that is used against Varicella-zoster virus infection. | | |
| West Nile virus ; NCBITaxon:11082 | West Nile virus | | |
| Yellow fever 17D vaccine vector ; VO:0000122 | a viral vaccine vector that uses Yellow fever vaccine strain 17D as the vector. | | |
| YF-Vax ; VO:0000121 | YF-Vax | | |
| Zika virus ; NCBITaxon:64320 | Found from reported data using NCBI Taxomony Dump: 64320 | | |
| Zostavax ; VO:0000124 | Zostavax | | |